(a) Medical cannabis packages and labels shall not be made to be attractive to children, to include cartoons; symbols or celebrities that are commonly used to market products to minors; or similar to existing packaging labels of any product available on the market that currently markets towards children.

(b) All prepared medical cannabis and medical cannabis product labels shall include the following information, prominently displayed and in a clear and legible font:

(1) the manufacture date, identification, batch, and lot number as applicable;

(2) the statement “”KEEP OUT OF REACH OF CHILDREN AND ANIMALS”” in bold print;
(3) the statement “”FOR MEDICAL USE ONLY””; (4) the statement, only on edibles “”WHEN
EATEN OR SWALLOWED, THE INTOXICATING EFFECTS OF THIS PRODUCT MAY BE DELAYED BY UP TO TWO HOURS””;

(5) the statement “”THIS PRODUCT MAY IMPAIR THE ABILITY TO DRIVE OR OPERATE MACHINERY. PLEASE USE EXTREME CAUTION””;

(6) a warning if nuts or other known allergens or gluten containing products are used;

175

COL 6/21/2023

10 Guam Code Ann. HEALTH AND SAFETY
CH. 12 MEDICAL PRACTICES

(7) a list of pharmacologically active ingredients, including, but not limited to, delta-9- tetrahydrocannabinol (THC) and cannabidiol (CBD) in percentage, the THC and CBD milligrams per serving, servings per package, and the THC and CBD and other cannabinoid amount in milligrams for the package total for prepared cannabis, as applicable;

(8) clear indication, in bold type, that the product contains medical cannabis;

(9) total net weight of prepared cannabis and medical cannabis product, as applicable; and

(10) any other requirement set by the DPHSS.

(c) All packaging information required by this Section shall be in no less than eight (8) point font, regardless of individual package size.

(d) Packaging shall be in an inconspicuous and tamper- evident packaging.

SOURCE: Added as part of the amendments by P.L. 33-220:2 (Dec. 17,
2016).